Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 1310 questions Show Answers
To ask the Scottish Government what its position is on the delivery of chemotherapy services by hospitals with areas of significant deprivation in their catchment areas.
To ask the Scottish Government what proportion of the New Medicines Fund will be funded by the pharmaceutical industry rebate payment made through the Pharmaceutical Price Regulation Scheme.
To ask the Scottish Government whether medicines approved by the Scottish Medicines Consortium will be eligible for funding by the New Medicines Fund.
To ask the Scottish Government what the eligibility criteria is for medicines to be funded by the New Medicines Fund.
To ask the Scottish Government how it is supporting local authorities in planning for owner-occupied housing for (a) older and (b) disabled people, as set out in paragraph 132 of Scottish Planning Policy.
To ask the Scottish Government how it will ensure fair application of affordable housing policy for specialised housing for older people, as set out in paragraph 129 of Scottish Planning Policy.
To ask the Scottish Government what role the private sector has in helping to provide owner-occupied retirement housing.
To ask the Scottish Government, in light of the recent statistics suggesting that the number of sheltered and very sheltered homes has decreased by 2,000 since 1996 and the expected increase in the number of older people, whether it has or will set targets for local authorities to construct owner-occupied retirement housing.
To ask the Scottish Government what its position is on the restoration of an outreach chemotherapy service by Stobhill Hospital.
To ask the Scottish Government how much the NHS has spent in each of the last four years on procuring drugs, broken down by pharmaceutical company.